PR Newswire - Laminar Pharma Announces first open-label Progress...
PALMA DE MALLORCA, Spain, March 5, 2025 /PRNewswire/ -- Laminar Pharma, a leader in the development of innovative cancer therapy based on membrane lipid therapy, announced today optimistic resu...
Read More

ภาษาไทย
English